Mechanistically, blockade of autophagy enhances the expression of p53 and activates BAX- and PUMA-dependent apoptotic responses in AML [119], suggesting that intact p53 function is required for autophagy-targeting therapeutics to be effective against AML. This evidence concerns the gene TP53 and acute myeloid leukemia.